FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37914811000001108: Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Dec 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
567361000001115 Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
567371000001113 Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Is a Iloprost 20micrograms/1ml nebuliser liquid ampoules with device true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Is a Ventavis true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Iloprost true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has specific active ingredient Iloprost trometamol true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) 168 ampoule 4 x 42 ampoules Has AMP True Ventavis 20micrograms/ml nebuliser solution 1ml ampoules with Breelib (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start